Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × guadecitabine × 90 days × Clear all

Sponsor

Conditions

Pheochromocytoma 1 Paraganglioma 1 Myelodysplastic Syndromes 1 Leukemia, Myelomonocytic, Chronic 1 Kidney Neoplasms 1 Gastrointestinal Stromal Tumors 1 Carcinoma, Renal Cell 1

Interventions

pembrolizumab 27 enfortumab vedotin 16 Nivolumab 14 Gemcitabine 12 avelumab 10 Magnetic Resonance Spectroscopy 10 Cisplatin 10 Carboplatin 10 Specimen Handling 9 sacituzumab govitecan 6 atezolizumab 6 durvalumab 5 Ipilimumab 5 Docetaxel 5 Paclitaxel 4 cabozantinib 3 Taxes 3 tislelizumab 2 relatlimab 2 lenvatinib 2 erdafitinib 2 Radiosurgery 2 Platinum 2 Oxaliplatin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 Cryosurgery 2 CTLA-4 Antigen 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡